Neusentis entered the industry of Commercial Medical Research in 1992 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417112, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact P Kay Wagoner, Chief Executive Officer by calling (919) 941-5206 during business hours. You can also write to the business’ Single Location at 4222 Emperor Boulevard # 350, Durham, North Carolina NC 27703. You can also visit the company’s website at neusentis.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Neusentis |
Representative: | P Kay Wagoner, Chief Executive Officer |
Place of Business: | 4222 Emperor Boulevard # 350, Durham, NC 27703 |
Contact Number: | (919) 941-5206 |
Website: | neusentis.com |
Type of Service: | Commercial Medical Research |
SIC Number: | 8731 |
NAICS Number: | 5417112 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 1992 |
Income/Year: | Unknown |
Laborers: | 1 to 4 |
Share This Company: |
Neusentis is a company operating from Durham, North Carolina providing professional Commercial Medical Research and relevant B2B variables. It was founded in 1992 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 5417112 as Commercial Medical Research.
With a current employee count of 1 to 4, Neusentis has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative P Kay Wagoner, Chief Executive Officer at (919) 941-5206 for related queries, or to locate its Single Location using the coordinates 35.87328,-78.84678.
The Single Location can also be found at the street address 4222 Emperor Boulevard # 350 in Durham, North Carolina 27703 and can be engaged online through the company website at neusentis.com, the company Twitter , and Facebook page .